Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US.

摘要: Abstract Background While many clinicians encounter parents or adolescents who refuse HPV vaccine, little is known about the prevalence of hesitancy for vaccine nationally its association with vaccination. Methods In April 2019, we surveyed families 11–17 years using a national online panel (Knowledge Panel®) as sampling frame. We assessed validated 9-item Vaccine Hesitancy Scale (VHS). used multivariate analyses to assess demographic factors associated hesitancy. also practical barriers receipt and relationship between Finally, evaluated both on refusal. Results 2,177 out 4,185 sampled (52%) completed survey, 2,020 qualified (lived adolescent). Using VHS cut-off score > 3 5 points, 23% US were hesitant vaccine. was lower among those Hispanic ethnicity. At least one five disagreed that beneficial their adolescent, effective, protects against HPV-related cancers, they followed adolescent’s health-care provider’s recommendation Many concerned side effects novelty Adolescents living vaccine-hesitant less than one-third likely have received (RR = 0.29, 95% CI 0.24, 0.35) series 0.23, 0.36), 6-fold more refused because parental vaccine-related concerns (RR = 6.09, CI = 5.26, 7.04). Most independently but not Conclusions common strongly related under-vaccination